Symbicort contains formotorol, a long-acting, beta agonist bronchodilator, and budesonide, a corticosteroid. Combination drugs like Symbicort help by doing two things almost simultaneously - the bronchodilator relaxes and opens up constricted airways and the steroid helps to relieve associated swelling and inflammation of the airways. Both of these actions make it easier for the COPD patient to breathe.
As a new treatment option for COPD patients, the makers of Symbicort boast that the drug delivers lung function improvement and daily symptom control along with a rapid onset of action.
The approved dosage of Symbicort is 160/4.5 mcg, with two inhalations taken twice daily.
Important safety information includes, but is not limited to, the following:
- Symbicort is NOT a rescue inhaler and should not replace fast-acting inhalers to relieve acute COPD symptoms.
- Symbicort should not be used in patients who are experiencing rapidly deteriorating or life-threatening symptoms of COPD.
- When using Symbicort, don't use other long-acting beta agonist bronchodilators.
Read more about the use of Symbicort for COPD.
If you have tried Symbicort, why not post a comment below and let us know how it worked for you.
Photo © Flickr.com, user jemsweb